Aluminum hydroxide nanoparticle adjuvants can reduce the inflammatory response more efficiently in a mouse model of allergic asthma than traditional aluminum hydroxide adjuvants

Zeng,Yue; Zhou,Weikang

doi:10.3892/etm.2023.12327

Aluminum hydroxide nanoparticle adjuvants can reduce the inflammatory response more efficiently in a mouse model of allergic asthma than traditional aluminum hydroxide adjuvants

Authors:
- Yue Zeng
- Weikang Zhou
View Affiliations

Affiliations: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: November 28, 2023 https://doi.org/10.3892/etm.2023.12327
Article Number: 39
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Traditional aluminum hydroxide is widely used as a vaccine adjuvant. Despite its favorable safety profile, it can cause an inflammatory response at the injection sites. However, multiple studies have shown that aluminum hydroxide nanoparticles have more potent adjuvant activity than their traditional aluminum hydroxide counterparts as antigen carriers; it has also been found that the local inflammation caused by aluminum hydroxide nanoparticle adjuvants is milder than that of other adjuvants. The aim of the present study was to compare the degree of inflammatory response between the aluminum hydroxide nanoparticle adjuvants and the traditional aluminum hydroxide adjuvants in the desensitization treatment of a mouse model of house dust mite (HDM)‑induced allergic asthma. Mice were sensitized intraperitoneally with HDM. Subcutaneous desensitization was performed with PBS, traditional aluminum hydroxide adjuvants and aluminum hydroxide nanoparticle adjuvants. The mice were challenged and subsequently euthanized. The skin tissue at the local injection sites was assessed and specific indices were measured, such as the response of specific immunoglobulins, the airway hyper‑responsiveness (AHR), and the inflammation in the bronchoalveolar lavage and lung tissues. Early hypersensitivity responses were suppressed in mice treated with subcutaneous immunotherapy (SCIT). Both traditional aluminum hydroxide‑SCIT and aluminum hydroxide nanoparticle‑SCIT could inhibit AHR. However, aluminum hydroxide nanoparticle‑SCIT was able to significantly inhibit the secretion of eosinophils in the lung tissue and the production of type 2 cytokine Interleukin (IL)‑5 in blood compared with the corresponding effects noted by traditional aluminum hydroxide adjuvants. Moreover, the aluminum hydroxide nanoparticle group reduced the inflammatory response at the local injection site. Collectively, the data indicated that allergen‑specific immunotherapy using aluminum hydroxide nanoparticle adjuvants reduces lung and local inflammation compared with traditional aluminum hydroxide adjuvants.

View Figures

View References

1	Hoffmann HJ, Valovirta E, Pfaar O, Moingeon P, Schmid JM, Skaarup SH, Cardell LO, Simonsen K, Larché M, Durham SR and Sørensen P: Novel approaches and perspectives in allergen immunotherapy. Allergy. 72:1022–1034. 2017.PubMed/NCBI View Article : Google Scholar
2	Hammad H and Lambrecht BN: Barrier epithelial cells and the control of type 2 immunity. Immunity. 43:29–40. 2015.PubMed/NCBI View Article : Google Scholar
3	Zubeldia JM, Ferrer M, Dávila I and Justicia JL: Adjuvants in allergen-specific immunotherapy: Modulating and enhancing the immune response. J Invest Allergol Clin Immunol. 29:103–111. 2019.PubMed/NCBI View Article : Google Scholar
4	HogenEsch H, O'Hagan DT and Fox CB: Optimizing the utilization of aluminum adjuvants in vaccines: You might just get what you want. NPJ Vaccines. 3(51)2018.PubMed/NCBI View Article : Google Scholar
5	Ashman DM, Frankland AW, Brown HM, Feinberg JG and Langman MJ: Treatment of house dust allergy with pyridine extracted alum precipitated mite fortified house dust (Allpyral). Ann Allergy. 29:578–581. 1971.PubMed/NCBI
6	Moreno C, De San Pedro BS, Millán C, Panizo C, Martín S and Florido F: Exploratory study of tolerability and immunological effect of a short up-dosing immunotherapy phase with a standardised allergen extract derived from pollen of Olea europaea. Clin Transl Allergy. 5(27)2015.PubMed/NCBI View Article : Google Scholar
7	Ozden MG, Kefeli M, Aydin F, Senturk N, Canturk T and Turanli AY: Persistent subcutaneous nodules after immunotherapy injections for allergic asthma. J Cutan Pathol. 36:812–814. 2009.PubMed/NCBI View Article : Google Scholar
8	Mold M, Shardlow E and Exley C: Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations. Sci Rep. 6(31578)2016.PubMed/NCBI View Article : Google Scholar
9	Smith SR and Petillo J: IgE production in five inbred rat strains following immunization with alum-precipitated egg albumin. Int Arch Allergy Appl Immunol. 52:21–31. 1976.PubMed/NCBI View Article : Google Scholar
10	Li X, Aldayel AM and Cui Z: Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. J Control Release. 173:148–157. 2014.PubMed/NCBI View Article : Google Scholar
11	Yan S, Rolfe BE, Zhang B, Mohammed YH, Gu W and Xu ZP: Polarized immune responses modulated by layered double hydroxides nanoparticle conjugated with CpG. Biomaterials. 35:9508–9516. 2014.PubMed/NCBI View Article : Google Scholar
12	Oreskovic Z, Nechvatalova K, Krejci J, Kummer V and Faldyna M: Aspects of intradermal immunization with different adjuvants: The role of dendritic cells and Th1/Th2 response. PloS One. 14(e0211896)2019.PubMed/NCBI View Article : Google Scholar
13	Hou Y, Wang Y, Tang Y, Zhou Z, Tan L, Gong T, Zhang L and Sun X: Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses. J Control Release. 326:120–130. 2020.PubMed/NCBI View Article : Google Scholar
14	Amini Y, Moradi B and Fasihi-Ramandi M: Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis. Artif Cells Nanomed Biotechnol. 45:1331–1335. 2017.PubMed/NCBI View Article : Google Scholar
15	Chen Y, Yang F, Yang J, Hou Y, He L, Hu H and Lv F: Aluminum (oxy) hydroxide nanorods activate an early immune response in pseudomonas aeruginosa vaccine. ACS Appl Mater Interfaces. 10:43533–43542. 2018.PubMed/NCBI View Article : Google Scholar
16	Hesse L and Nawijn MC: Subcutaneous and sublingual immunotherapy in a mouse model of allergic asthma. Methods Mol Biol. 1559:137–168. 2017.PubMed/NCBI View Article : Google Scholar
17	Debeuf N, Haspeslagh E, van Helden M, Hammad H and Lambrecht BN: Mouse models of asthma. Curr Protoc Mouse Biol. 6:169–184. 2016.PubMed/NCBI View Article : Google Scholar
18	Li X, Hufnagel S, Xu H, Valdes SA, Thakkar SG, Cui Z and Celio H: Aluminum (Oxy)hydroxide nanosticks synthesized in bicontinuous reverse microemulsion have potent vaccine adjuvant activity. ACS Appl Mater Interfaces. 9:22893–22901. 2017.PubMed/NCBI View Article : Google Scholar
19	Chevigné A, Campizi V, Szpakowska M, Bourry D, Dumez ME, Martins JC, Matagne A, Galleni M and Jacquet A: The Lys-Asp-Tyr triad within the mite allergen Der p. 1 propeptide is a critical structural element for the pH-dependent initiation of the protease maturation. Int J Mol Sci. 18(1087)2017.PubMed/NCBI View Article : Google Scholar
20	NOON L: Prophylactic inoculation against hay fever. Int Arch Allergy Appl Immunol. 4:285–288. 1953.PubMed/NCBI View Article : Google Scholar
21	Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H, Jarjour NN, Busse WW and Kelly EA: Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol. 169:6452–6458. 2002.PubMed/NCBI View Article : Google Scholar
22	Karani LW, Tolo FM, Karanja SM and Khayeka CW: Safety and efficacy of prunus africana and warburgia ugandensis against induced asthma in BALB/c Mice. European J Med Plants. 3:345–368. 2013.
23	Tibbitt CA, Stark JM, Martens L, Ma J, Mold JE, Deswarte K, Oliynyk G, Feng X, Lambrecht BN, De Bleser P, et al: Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells. Immunity. 51:169–184.e5. 2019.PubMed/NCBI View Article : Google Scholar
24	Hesse L, van Ieperen N, Habraken C, Petersen AH, Korn S, Smilda T, Goedewaagen B, Ruiters MH, van der Graaf AC and Nawijn MC: Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model. Allergy. 73:862–874. 2018.PubMed/NCBI View Article : Google Scholar